Outset Medical (NASDAQ:OM) reported quarterly losses of $(0.39) per share which beat the analyst consensus estimate of $(0.42) by 7.14 percent. The company reported quarterly sales of $28.666 million which beat the analyst consensus estimate of $26.905 million by 6.55 percent. This is a 5.59 percent decrease over sales of $30.362 million the same period last year.